Inventor · disambiguated record
David L. Vesely
Also filed as: VESELY DAVID L · VESELY DAVID LYNN
9 granted patents·4 pending applications·185 citations·filing 1995–2015
89Inventor score
Top patents by PatentIndex Score
13 records- 0196US7846900B2Cancer treatment using C-type natriuretic peptideUNIV SOUTH FLORIDA·Filed 2008·Granted Dec 7, 2010·34 cites·6 claims
- 0296US7825092B2Dendroaspis natriuretic peptide for treatment of cancerUNIV SOUTH FLORIDA·Filed 2007·Granted Nov 2, 2010·38 cites·17 claims
- 0393US7488713B2Cancer treatment using C-type natriuretic peptidesUNIV SOUTH FLORIDA·Filed 2005·Granted Feb 10, 2009·32 cites·4 claims
- 0485US8343919B2Cancer treatment using natriuretic peptidesUNIV SOUTH FLORIDA·Filed 2010·Granted Jan 1, 2013·3 cites·5 claims
- 0585US6943147B2Cancer treatment using proANP peptidesUNIV SOUTH FLORIDA·Filed 2004·Granted Sep 13, 2005·19 cites·10 claims
- 0679US8759317B2Method of treatment of cancer using guanosine 3′, 5′ cyclic monophosphate (cyclic GMP)VESELY DAVID L·Filed 2005·Granted Jun 24, 2014·2 cites·18 claims
- 0778US5691310AMethods of treatment using proANF peptidesFiled 1995·Granted Nov 25, 1997·57 cites·25 claims
- 0860US2009062206A1Urodilatin Cancer TreatmentUNIV SOUTH FLORIDA·Filed 2008·Application pending·0 cites
- 0957US2013096061A1Method of treating skeletal dysplasias using vessel dilatorUNIV SOUTH FLORIDA·Filed 2012·Application pending·0 cites
- 1052US9956267B2Method of treating skeletal dysplasias using vessel dilatorVESELY DAVID LYNN·Filed 2015·Granted May 1, 2018·0 cites·10 claims
- 1152US2011034386A1Dendroaspis natriuretic peptide for treatment of cancerUS DEPT VETERANS AFFAIRS·Filed 2010·Application pending·0 cites
- 1245US2006205642A1Oral methods of treatment using proANF peptidesVESELY DAVID L·Filed 2005·Application pending·0 cites
- 1339US9808513B2Method of treatment of cancer using guanosine 3′, 5′ cyclic monophosphate (cyclic GMP)VESELY DAVID L·Filed 2014·Granted Nov 7, 2017·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when David L. Vesely files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →